CLX: Clorox Co Financial Statements
Balance sheet, income statement, and cash flow statements for Clorox Co (CLX).
$14.80B Market Cap.
CLX Market Cap. (MRY)
CLX Shares Outstanding (MRY)
CLX Assets (MRY)
Total Assets
$5.56B
Total Liabilities
$5.08B
Total Investments
$0
CLX Income (MRY)
Revenue
$7.10B
Net Income
$810.00M
Operating Expense
$1.93B
CLX Cash Flow (MRY)
CF Operations
$981.00M
CF Investing
-$94.00M
CF Financing
-$924.00M
CLX Balance Sheet (MRY)
Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total Assets | $5,561,000,000 (-3.30%) | $5,751,000,000 (-3.26%) | $5,945,000,000 (-3.46%) | $6,158,000,000 (-2.78%) |
Assets Current | $1,608,000,000 (-0.86%) | $1,622,000,000 (-11.27%) | $1,828,000,000 (5.97%) | $1,725,000,000 (-5.69%) |
Assets Non-Current | $3,953,000,000 (-4.26%) | $4,129,000,000 (0.29%) | $4,117,000,000 (-7.13%) | $4,433,000,000 (-1.60%) |
Goodwill & Intangible Assets | $1,795,000,000 (-5.97%) | $1,909,000,000 (-2.80%) | $1,964,000,000 (-19.57%) | $2,442,000,000 (-2.05%) |
Shareholders Equity | $321,000,000 (-2.13%) | $328,000,000 (49.09%) | $220,000,000 (-60.43%) | $556,000,000 (35.28%) |
Property Plant & Equipment Net | $1,600,000,000 (-4.48%) | $1,675,000,000 (-0.95%) | $1,691,000,000 (0.89%) | $1,676,000,000 (2.57%) |
Cash & Equivalents | $167,000,000 (-17.33%) | $202,000,000 (-44.96%) | $367,000,000 (100.55%) | $183,000,000 (-42.63%) |
Accumulated Other Comprehensive Income | -$157,000,000 (-1.29%) | -$155,000,000 (68.56%) | -$493,000,000 (-2.92%) | -$479,000,000 (12.27%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $523,000,000 (-17.90%) | $637,000,000 (-8.48%) | $696,000,000 (-7.81%) | $755,000,000 (0.40%) |
Trade & Non-Trade Receivables | $821,000,000 (18.13%) | $695,000,000 (1.02%) | $688,000,000 (1.03%) | $681,000,000 (12.75%) |
Trade & Non-Trade Payables | $1,828,000,000 (23.01%) | $1,486,000,000 (-10.43%) | $1,659,000,000 (12.93%) | $1,469,000,000 (-12.30%) |
Accumulated Retained Earnings (Deficit) | $432,000,000 (72.80%) | $250,000,000 (-57.12%) | $583,000,000 (-44.37%) | $1,048,000,000 (1.16%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $20,000,000 (-9.09%) | $22,000,000 (-85.23%) | $149,000,000 (125.76%) | $66,000,000 (-1.49%) |
Total Debt | $2,880,000,000 (-0.79%) | $2,903,000,000 (-0.72%) | $2,924,000,000 (-5.77%) | $3,103,000,000 (-1.99%) |
Debt Current | $91,000,000 (3.41%) | $88,000,000 (-35.77%) | $137,000,000 (-56.51%) | $315,000,000 (-17.32%) |
Debt Non-Current | $2,789,000,000 (-0.92%) | $2,815,000,000 (1.00%) | $2,787,000,000 (-0.04%) | $2,788,000,000 (0.11%) |
Total Liabilities | $5,079,000,000 (-3.42%) | $5,259,000,000 (-5.36%) | $5,557,000,000 (2.36%) | $5,429,000,000 (-5.45%) |
Liabilities Current | $1,919,000,000 (21.92%) | $1,574,000,000 (-17.89%) | $1,917,000,000 (7.46%) | $1,784,000,000 (-13.23%) |
Liabilities Non-Current | $3,160,000,000 (-14.25%) | $3,685,000,000 (1.24%) | $3,640,000,000 (-0.14%) | $3,645,000,000 (-1.11%) |
CLX Income Statement (MRY)
Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Revenues | $7,104,000,000 (0.16%) | $7,093,000,000 (-4.01%) | $7,389,000,000 (3.97%) | $7,107,000,000 (-3.19%) |
Cost of Revenue | $3,891,000,000 (-3.81%) | $4,045,000,000 (-9.73%) | $4,481,000,000 (-1.78%) | $4,562,000,000 (10.14%) |
Selling General & Administrative Expense | $1,894,000,000 (-5.25%) | $1,999,000,000 (4.28%) | $1,917,000,000 (15.27%) | $1,663,000,000 (-7.30%) |
Research & Development Expense | $121,000,000 (-3.97%) | $126,000,000 (-8.70%) | $138,000,000 (4.55%) | $132,000,000 (-11.41%) |
Operating Expenses | $1,929,000,000 (-16.85%) | $2,320,000,000 (-10.08%) | $2,580,000,000 (40.83%) | $1,832,000,000 (-16.73%) |
Interest Expense | $88,000,000 (-2.22%) | $90,000,000 (0.00%) | $90,000,000 (-15.09%) | $106,000,000 (7.07%) |
Income Tax Expense | $254,000,000 (139.62%) | $106,000,000 (37.66%) | $77,000,000 (-43.38%) | $136,000,000 (-24.86%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | $824,000,000 (182.19%) | $292,000,000 (81.37%) | $161,000,000 (-65.82%) | $471,000,000 (-34.49%) |
Net Income to Non-Controlling Interests | $14,000,000 (16.67%) | $12,000,000 (0.00%) | $12,000,000 (33.33%) | $9,000,000 (0.00%) |
Net Income | $810,000,000 (189.29%) | $280,000,000 (87.92%) | $149,000,000 (-67.75%) | $462,000,000 (-34.93%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | $810,000,000 (189.29%) | $280,000,000 (87.92%) | $149,000,000 (-67.75%) | $462,000,000 (-34.93%) |
Weighted Average Shares | $123,525,000 (-0.52%) | $124,174,000 (0.47%) | $123,589,000 (0.39%) | $123,113,000 (-1.96%) |
Weighted Average Shares Diluted | $124,287,000 (-0.41%) | $124,804,000 (0.50%) | $124,181,000 (0.22%) | $123,906,000 (-2.67%) |
Earning Before Interest & Taxes (EBIT) | $1,152,000,000 (142.02%) | $476,000,000 (50.63%) | $316,000,000 (-55.11%) | $704,000,000 (-28.89%) |
Gross Profit | $3,213,000,000 (5.41%) | $3,048,000,000 (4.81%) | $2,908,000,000 (14.26%) | $2,545,000,000 (-20.44%) |
Operating Income | $1,284,000,000 (76.37%) | $728,000,000 (121.95%) | $328,000,000 (-54.00%) | $713,000,000 (-28.63%) |
CLX Cash Flow Statement (MRY)
Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$94,000,000 (46.29%) | -$175,000,000 (21.52%) | -$223,000,000 (2.62%) | -$229,000,000 (49.34%) |
Net Cash Flow from Financing | -$924,000,000 (-41.07%) | -$655,000,000 (13.01%) | -$753,000,000 (-9.29%) | -$689,000,000 (50.47%) |
Net Cash Flow from Operations | $981,000,000 (41.15%) | $695,000,000 (-39.98%) | $1,158,000,000 (47.33%) | $786,000,000 (-38.40%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$37,000,000 (77.02%) | -$161,000,000 (-188.46%) | $182,000,000 (231.88%) | -$138,000,000 (75.14%) |
Net Cash Flow - Business Acquisitions and Disposals | $128,000,000 (652.94%) | $17,000,000 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$220,000,000 (-3.77%) | -$212,000,000 (7.02%) | -$228,000,000 (9.16%) | -$251,000,000 (24.17%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | -$45,000,000 (76.06%) | -$188,000,000 (-126.51%) | -$83,000,000 (0%) |
Issuance (Purchase) of Equity Shares | -$306,000,000 (-30700.00%) | $1,000,000 (-96.97%) | $33,000,000 (265.00%) | -$20,000,000 (97.51%) |
Payment of Dividends & Other Cash Distributions | -$602,000,000 (-1.18%) | -$595,000,000 (-2.06%) | -$583,000,000 (-2.10%) | -$571,000,000 (-2.33%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | -$26,000,000 (0%) | $0 (0%) | -$6,000,000 (-150.00%) |
Share Based Compensation | $81,000,000 (9.46%) | $74,000,000 (1.37%) | $73,000,000 (40.38%) | $52,000,000 (4.00%) |
Depreciation Amortization & Accretion | $219,000,000 (-6.81%) | $235,000,000 (-0.42%) | $236,000,000 (5.36%) | $224,000,000 (6.16%) |
CLX Financial Metrics (MRY)
Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Gross Margin | 45.20% (5.12%) | 43.00% (9.14%) | 39.40% (10.06%) | 35.80% (-17.89%) |
Profit Margin | 11.40% (192.31%) | 3.90% (95.00%) | 2.00% (-69.23%) | 6.50% (-32.99%) |
EBITDA Margin | 19.30% (93.00%) | 10.00% (33.33%) | 7.50% (-42.75%) | 13.10% (-20.12%) |
Return on Average Equity (ROAE) | 882.80% (242.83%) | 257.50% (275.91%) | 68.50% (-39.33%) | 112.90% (37.35%) |
Return on Average Assets (ROAA) | 14.60% (204.17%) | 4.80% (92.00%) | 2.50% (-66.22%) | 7.40% (-31.48%) |
Return on Sales (ROS) | 16.20% (141.79%) | 6.70% (55.81%) | 4.30% (-56.57%) | 9.90% (-26.67%) |
Return on Invested Capital (ROIC) | 25.00% (150.00%) | 10.00% (47.06%) | 6.80% (-58.02%) | 16.20% (-23.22%) |
Dividend Yield | 4.10% (17.14%) | 3.50% (16.67%) | 3.00% (-9.09%) | 3.30% (32.00%) |
Price to Earnings Ratio (P/E) | 18.3 (-69.69%) | 60.38 (-54.06%) | 131.44 (249.62%) | 37.59 (18.28%) |
Price to Sales Ratio (P/S) | 2.09 (-12.60%) | 2.39 (-10.19%) | 2.66 (8.93%) | 2.44 (-20.64%) |
Price to Book Ratio (P/B) | 46.1 (-10.78%) | 51.67 (-42.18%) | 89.37 (186.37%) | 31.21 (-42.68%) |
Debt to Equity Ratio (D/E) | 15.82 (-1.32%) | 16.03 (-36.52%) | 25.26 (158.70%) | 9.76 (-30.11%) |
Earnings Per Share (EPS) | 6.56 (190.27%) | 2.26 (86.78%) | 1.21 (-67.73%) | 3.75 (-33.75%) |
Sales Per Share (SPS) | 57.51 (0.68%) | 57.12 (-4.46%) | 59.79 (3.57%) | 57.73 (-1.26%) |
Free Cash Flow Per Share (FCFPS) | 6.16 (58.38%) | 3.89 (-48.31%) | 7.53 (73.15%) | 4.35 (-42.25%) |
Book Value Per Share (BVPS) | 2.6 (-1.59%) | 2.64 (48.37%) | 1.78 (-60.58%) | 4.52 (37.98%) |
Tangible Assets Book Value Per Share (TABVPS) | 30.49 (-1.46%) | 30.94 (-3.95%) | 32.21 (6.72%) | 30.18 (-1.32%) |
Enterprise Value Over EBIT (EV/EBIT) | 15 (-63.41%) | 41 (-42.25%) | 71 (144.83%) | 29 (16.00%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 12.78 (-54.00%) | 27.78 (-31.69%) | 40.66 (85.38%) | 21.93 (5.17%) |
Asset Turnover | 1.28 (6.03%) | 1.21 (-1.94%) | 1.23 (8.25%) | 1.14 (2.52%) |
Current Ratio | 0.84 (-18.64%) | 1.03 (7.97%) | 0.95 (-1.34%) | 0.97 (8.65%) |
Dividends | $4.88 (1.67%) | $4.8 (1.69%) | $4.72 (1.72%) | $4.64 (4.50%) |
Free Cash Flow (FCF) | $761,000,000 (57.56%) | $483,000,000 (-48.06%) | $930,000,000 (73.83%) | $535,000,000 (-43.39%) |
Enterprise Value (EV) | $17,516,964,536 (-11.30%) | $19,748,962,016 (-12.01%) | $22,444,085,257 (10.27%) | $20,353,817,413 (-18.73%) |
Earnings Before Tax (EBT) | $1,064,000,000 (175.65%) | $386,000,000 (70.80%) | $226,000,000 (-62.21%) | $598,000,000 (-32.88%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | $1,371,000,000 (92.83%) | $711,000,000 (28.80%) | $552,000,000 (-40.52%) | $928,000,000 (-22.73%) |
Invested Capital | $4,560,000,000 (-8.23%) | $4,969,000,000 (7.53%) | $4,621,000,000 (-4.76%) | $4,852,000,000 (4.75%) |
Working Capital | -$311,000,000 (-747.92%) | $48,000,000 (153.93%) | -$89,000,000 (-50.85%) | -$59,000,000 (74.01%) |
Tangible Asset Value | $3,766,000,000 (-1.98%) | $3,842,000,000 (-3.49%) | $3,981,000,000 (7.13%) | $3,716,000,000 (-3.25%) |
Market Capitalization | $14,798,964,536 (-12.68%) | $16,947,962,016 (-13.80%) | $19,661,085,257 (13.31%) | $17,351,817,413 (-22.45%) |
Average Equity | $91,750,000 (-15.63%) | $108,750,000 (-50.00%) | $217,500,000 (-46.85%) | $409,250,000 (-52.59%) |
Average Assets | $5,536,750,000 (-5.58%) | $5,863,750,000 (-2.11%) | $5,990,250,000 (-3.94%) | $6,236,000,000 (-5.54%) |
Invested Capital Average | $4,602,500,000 (-3.21%) | $4,755,250,000 (2.44%) | $4,642,000,000 (6.64%) | $4,353,000,000 (-7.23%) |
Shares | 123,252,807 (-0.75%) | 124,188,188 (0.46%) | 123,623,524 (0.44%) | 123,079,993 (-1.04%) |
